Entertainment
Compare Stocks
4 / 10Stock Comparison
GAIA vs AMCX vs WBD vs CURI
Revenue, margins, valuation, and 5-year total return — side by side.
Entertainment
Entertainment
Broadcasting
GAIA vs AMCX vs WBD vs CURI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Entertainment | Entertainment | Entertainment | Broadcasting |
| Market Cap | $62M | $98M | $67.98B | $184M |
| Revenue (TTM) | $99M | $2.32B | $37.21B | $72M |
| Net Income (TTM) | $-5M | $-140M | $-2.15B | $-6M |
| Gross Margin | 86.7% | 51.0% | 41.5% | 56.6% |
| Operating Margin | -5.6% | -3.0% | -4.0% | -10.2% |
| Forward P/E | — | 5.0x | 93.5x | 89.7x |
| Total Debt | $9M | $0.00 | $32.57B | $12M |
| Cash & Equiv. | $14M | — | $4.57B | $18M |
GAIA vs AMCX vs WBD vs CURI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gaia, Inc. (GAIA) | 100 | 31.7 | -68.3% |
| AMC Networks Inc. (AMCX) | 100 | 30.3 | -69.7% |
| Warner Bros. Discov… (WBD) | 100 | 124.7 | +24.7% |
| CuriosityStream Inc. (CURI) | 100 | 32.1 | -67.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GAIA vs AMCX vs WBD vs CURI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GAIA is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 1.39
- -4.8% margin vs CURI's -9.0%
AMCX has the current edge in this matchup, primarily because of its strength in value and stability.
- Lower P/E (5.0x vs 89.7x)
- Beta 0.86 vs CURI's 1.44
WBD is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- -3.7% 10Y total return vs GAIA's -62.8%
- Lower volatility, beta 0.90, Low D/E 87.6%, current ratio 1.06x
- Beta 0.90, current ratio 1.06x
- +216.8% vs GAIA's -51.8%
CURI is the clearest fit if your priority is growth exposure.
- Rev growth 40.1%, EPS growth 54.2%, 3Y rev CAGR -2.8%
- 40.1% revenue growth vs WBD's -5.1%
- 12.2% yield; 2-year raise streak; the other 3 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.1% revenue growth vs WBD's -5.1% | |
| Value | Lower P/E (5.0x vs 89.7x) | |
| Quality / Margins | -4.8% margin vs CURI's -9.0% | |
| Stability / Safety | Beta 0.86 vs CURI's 1.44 | |
| Dividends | 12.2% yield; 2-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +216.8% vs GAIA's -51.8% | |
| Efficiency (ROA) | -2.2% ROA vs CURI's -8.2%, ROIC 1.5% vs -12.2% |
GAIA vs AMCX vs WBD vs CURI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GAIA vs AMCX vs WBD vs CURI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
WBD leads in 2 of 6 categories
AMCX leads 1 • CURI leads 1 • GAIA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — GAIA and AMCX and CURI each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WBD is the larger business by revenue, generating $37.2B annually — 519.3x CURI's $72M. Profitability is closely matched — net margins range from -4.8% (GAIA) to -9.0% (CURI). On growth, CURI holds the edge at +35.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $99M | $2.3B | $37.2B | $72M |
| EBITDAEarnings before interest/tax | $6M | $686M | $7.5B | $14M |
| Net IncomeAfter-tax profit | -$5M | -$140M | -$2.2B | -$6M |
| Free Cash FlowCash after capex | -$776,000 | $267M | $2.3B | $13M |
| Gross MarginGross profit ÷ Revenue | +86.7% | +51.0% | +41.5% | +56.6% |
| Operating MarginEBIT ÷ Revenue | -5.6% | -3.0% | -4.0% | -10.2% |
| Net MarginNet income ÷ Revenue | -4.8% | -6.0% | -5.8% | -9.0% |
| FCF MarginFCF ÷ Revenue | -0.8% | +11.5% | +6.2% | +18.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | -6.3% | -1.0% | +35.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -20.2% | -10.4% | -5.5% | -31.2% |
Valuation Metrics
AMCX leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMCX's 0.1x EV/EBITDA is more attractive than CURI's 24.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $62M | $98M | $68.0B | $184M |
| Enterprise ValueMkt cap + debt − cash | $58M | $98M | $96.0B | $179M |
| Trailing P/EPrice ÷ TTM EPS | -13.78x | — | 93.52x | -28.55x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 5.04x | — | 89.71x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 4.33x | 0.08x | 13.73x | 24.22x |
| Price / SalesMarket cap ÷ Revenue | 0.63x | 0.04x | 1.82x | 2.57x |
| Price / BookPrice ÷ Book value/share | 0.61x | — | 1.85x | 4.36x |
| Price / FCFMarket cap ÷ FCF | — | 0.32x | 22.02x | 14.24x |
Profitability & Efficiency
WBD leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
GAIA delivers a -4.7% return on equity — every $100 of shareholder capital generates $-5 in annual profit, vs $-13 for CURI. GAIA carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to WBD's 0.88x. On the Piotroski fundamental quality scale (0–9), GAIA scores 6/9 vs AMCX's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.7% | -12.2% | -5.9% | -13.1% |
| ROA (TTM)Return on assets | -3.1% | -3.3% | -2.2% | -8.2% |
| ROICReturn on invested capital | -3.9% | +12.1% | +1.5% | -12.2% |
| ROCEReturn on capital employed | -4.7% | — | +1.5% | -13.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.09x | — | 0.88x | 0.30x |
| Net DebtTotal debt minus cash | -$4M | $0 | $28.0B | -$6M |
| Cash & Equiv.Liquid assets | $14M | — | $4.6B | $18M |
| Total DebtShort + long-term debt | $9M | $0 | $32.6B | $12M |
| Interest CoverageEBIT ÷ Interest expense | — | 0.95x | 3.56x | — |
Total Returns (Dividends Reinvested)
WBD leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WBD five years ago would be worth $7,220 today (with dividends reinvested), compared to $1,813 for AMCX. Over the past 12 months, WBD leads with a +216.8% total return vs GAIA's -51.8%. The 3-year compound annual growth rate (CAGR) favors CURI at 54.7% vs AMCX's -17.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -29.1% | -7.5% | -4.9% | -14.4% |
| 1-Year ReturnPast 12 months | -51.8% | +29.1% | +216.8% | -23.1% |
| 3-Year ReturnCumulative with dividends | -17.9% | -44.0% | +101.5% | +270.5% |
| 5-Year ReturnCumulative with dividends | -77.7% | -81.9% | -27.8% | -70.2% |
| 10-Year ReturnCumulative with dividends | -62.8% | -87.4% | -3.7% | -63.2% |
| CAGR (3Y)Annualised 3-year return | -6.4% | -17.6% | +26.3% | +54.7% |
Risk & Volatility
Evenly matched — AMCX and WBD each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMCX is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than CURI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WBD currently trades 90.4% from its 52-week high vs GAIA's 38.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.39x | 0.86x | 0.90x | 1.44x |
| 52-Week HighHighest price in past year | $6.39 | $10.18 | $30.00 | $7.15 |
| 52-Week LowLowest price in past year | $2.42 | $5.41 | $8.06 | $2.81 |
| % of 52W HighCurrent price vs 52-week peak | +38.8% | +84.1% | +90.4% | +43.9% |
| RSI (14)Momentum oscillator 0–100 | 34.9 | 57.3 | 48.9 | 43.0 |
| Avg Volume (50D)Average daily shares traded | 71K | 386K | 22.2M | 349K |
Analyst Outlook
CURI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AMCX as "Hold", WBD as "Hold", CURI as "Buy". Consensus price targets imply 16.9% upside for CURI (target: $4) vs -6.5% for AMCX (target: $8). CURI is the only dividend payer here at 12.16% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $8.00 | $29.94 | $3.67 |
| # AnalystsCovering analysts | — | 40 | 32 | 9 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +12.2% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 1 | 2 |
| Dividend / ShareAnnual DPS | — | — | — | $0.38 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
WBD leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). AMCX leads in 1 (Valuation Metrics). 2 tied.
GAIA vs AMCX vs WBD vs CURI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GAIA or AMCX or WBD or CURI a better buy right now?
For growth investors, CuriosityStream Inc.
(CURI) is the stronger pick with 40. 1% revenue growth year-over-year, versus -5. 1% for Warner Bros. Discovery, Inc. (WBD). Warner Bros. Discovery, Inc. (WBD) offers the better valuation at 93. 5x trailing P/E, making it the more compelling value choice. Analysts rate CuriosityStream Inc. (CURI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GAIA or AMCX or WBD or CURI?
On forward P/E, AMC Networks Inc.
is actually cheaper at 5. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GAIA or AMCX or WBD or CURI?
Over the past 5 years, Warner Bros.
Discovery, Inc. (WBD) delivered a total return of -27. 8%, compared to -81. 9% for AMC Networks Inc. (AMCX). Over 10 years, the gap is even starker: WBD returned -3. 7% versus AMCX's -87. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GAIA or AMCX or WBD or CURI?
By beta (market sensitivity over 5 years), AMC Networks Inc.
(AMCX) is the lower-risk stock at 0. 86β versus CuriosityStream Inc. 's 1. 44β — meaning CURI is approximately 68% more volatile than AMCX relative to the S&P 500. On balance sheet safety, Gaia, Inc. (GAIA) carries a lower debt/equity ratio of 9% versus 88% for Warner Bros. Discovery, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GAIA or AMCX or WBD or CURI?
By revenue growth (latest reported year), CuriosityStream Inc.
(CURI) is pulling ahead at 40. 1% versus -5. 1% for Warner Bros. Discovery, Inc. (WBD). On earnings-per-share growth, the picture is similar: Warner Bros. Discovery, Inc. grew EPS 106. 3% year-over-year, compared to 18. 2% for Gaia, Inc.. Over a 3-year CAGR, GAIA leads at 6. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GAIA or AMCX or WBD or CURI?
AMC Networks Inc.
(AMCX) is the more profitable company, earning 8. 4% net margin versus -9. 0% for CuriosityStream Inc. — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMCX leads at 5. 8% versus -10. 2% for CURI. At the gross margin level — before operating expenses — GAIA leads at 87. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GAIA or AMCX or WBD or CURI more undervalued right now?
On forward earnings alone, AMC Networks Inc.
(AMCX) trades at 5. 0x forward P/E versus 89. 7x for CuriosityStream Inc. — 84. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CURI: 16. 9% to $3. 67.
08Which pays a better dividend — GAIA or AMCX or WBD or CURI?
In this comparison, CURI (12.
2% yield) pays a dividend. GAIA, AMCX, WBD do not pay a meaningful dividend and should not be held primarily for income.
09Is GAIA or AMCX or WBD or CURI better for a retirement portfolio?
For long-horizon retirement investors, Warner Bros.
Discovery, Inc. (WBD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90)). Both have compounded well over 10 years (WBD: -3. 7%, GAIA: -62. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GAIA and AMCX and WBD and CURI?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GAIA is a small-cap quality compounder stock; AMCX is a small-cap quality compounder stock; WBD is a mid-cap quality compounder stock; CURI is a small-cap high-growth stock. CURI pays a dividend while GAIA, AMCX, WBD do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 17%
- Gross Margin > 33%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.